Joint Formulary & PAD

Itulazax (birch pollen) - Allergen immunotherapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral lyophilisates
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Ituluzax (birch pollen) - RSFT Immunology only. Approved for over 18s only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Itulazax (birch pollen)
Indication :
Allergen immunotherapy
Group Name :
Keywords :
Brand Names Include :
Itulazax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Itulazax (birch pollen) is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.